Crohn's disease: open trials in Austria

18 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

2024-518296-56-00
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-11-08
NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten · Medical University of Vienna, Vienna
Registry updated 2026-11-04
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Medizinische Universität Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Medizinische Universität Wien, Vienna
Registry updated 2026-11-04
NCT05923073
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Medical University of Vienna, Vienna
Registry updated 2026-11-03
NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Lkh-Univ. Klinikum Graz, Graz · Medizinische Universitatsklinik Innsbruck, Innsbruck · Kepler Universitatsklinikum GmbH, Linz · LKH - Universitätsklinikum der PMU Salzburg, Salzburg · Krankenhaus der Barmherzigen Brüder, Vienna · Medical University Vienna, Vienna · Klinikum Wels-Grieskirchen, Wels · Universitätsklinikum Wiener Neustadt, Wiener Neustadt
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Medical University of Graz, Graz · Landeskrankenanstalten-Betriebsgesellschaft Kabeg, Klagenfurt Am Woerthersee · Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten · Krankenhaus Der Barmherzigen Brueder Wien, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-11-03
NCT07606339
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
Research · Janssen-Cilag Pharma GmbH
Medical University Vienna, Vienna
Registry updated 2026-11-03
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna
Registry updated 2026-11-02
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Ordensklinikum Linz GmbH, Linz · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Graz · Krems · Linz · Salzburg · Sankt Veit an der Glan · Vienna · Vienna · Vienna
Registry updated 2026-10-21
NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Vienna
Registry updated 2026-10-21
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Medizinische Universitaet Innsbruck, Innsbruck · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten · Krankenhaus Der Barmherzigen Brueder Wien, Vienna · Medical University of Vienna, Vienna
Registry updated 2026-10-16
2026-525197-19-00
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
Trial Treatment · Phase 2 · Agomab Spain S.L.U.
Medical University of Graz, Graz · Landeskrankenanstalten-Betriebsgesellschaft Kabeg, Klagenfurt Am Woerthersee · Ordensklinikum Linz GmbH, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Noe LGA Gesundheit Region Mitte GmbH, Tulln An Der Donau · Medical University of Vienna, Vienna
Registry updated 2026-10-14
NCT04844606
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Trial Treatment · Phase 3 · Eli Lilly and Company
Medizinische Universität Wien, Vienna
Registry updated 2026-10-07
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Trial Treatment · Phase 3 · Eli Lilly and Company
Medical University of Vienna, Vienna
Registry updated 2026-10-07
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Ordensklinikum Linz GmbH, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels
Registry updated 2026-09-25
2025-521590-13-00
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Trial Treatment · Phase 3 · Janssen Cilag International
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Krankenhaus Der Barmherzigen Brueder Wien, Vienna · Medical University of Vienna, Vienna · Klinikum Wels-Grieskirchen GmbH, Wels · Noe LGA Gesundheit Thermenregion GmbH, Wiener Neustadt
Registry updated 2026-08-28
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Medizinische Universitaet Innsbruck, Innsbruck · Kepler Universitaetsklinikum GmbH, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · Medical University of Vienna, Vienna · Krankenhaus Der Barmherzigen Brueder Wien, Vienna
Registry updated 2026-05-27

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error